Total investments 16
Average round size 
$263M
The average size of a deal this fund participated in
Portfolio companies 15
Lead investments 6
Follow on index
0.06How often the fund supports its portfolio startups at next rounds
Exits 12
Key employees Soon
Cambridge, Massachusetts, United States Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Blackstone Life Sciences:
Typical Co-investors
Blackstone Life Sciences is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Blackstone Life Sciences:
There are no funds here. If we find new data, we will add it here.
Funds with similar focus
Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Anhui Transportation Holding Group | Anhui, China, Hefei |
| Arcview Collective Fund | California, San Francisco, United States |
| Canon Marketing Japan | Japan, Tokyo |
| Cinemagic | - |
| CRISIL | India, Maharashtra, Mumbai |
| Elara Technologies | Central, Central Region, Singapore |
| Elevage Capital Management | Dallas, Texas, United States |
| Evergreen Investments | Boston, Massachusetts, United States |
| Guanqun Investment | England, London, United Kingdom |
| HALLMANN HOLDING International Investment GmbH | - |
| IFC InfraVentures | District of Columbia, United States, Washington |
| MSD Partners | New York, New York, United States |
| OpenSource Ventures | - |
| Pharos Capital Partners | Dallas, Texas, United States |
| Scheer Partners Investments | Maryland, Rockville, United States |
| Stow Capital | - |
| Synergy Capital Partners | Medina, Ohio, United States |
| Wutongshu Capital | - |
| Yizhuang Biomedical Mergers and Acquisition Funds | China, Jiangsu, Yizhuang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
AvenCell | 22 Oct 2024 | Cambridge, Massachusetts, United States | |||
Uniquity Bio | $300M | 15 May 2024 | Malvern, Pennsylvania, United States | ||
Talaris Therapeutics | $115M | 06 Oct 2020 | Massachusetts, United States | ||
Praxis Precision Medicines | $110M | 28 Jul 2020 | Cambridge, Massachusetts, United States | ||
Annexon Biosciences | $100M | 01 Jul 2020 | South San Francisco, California, United States | ||
Anthos Therapeutics | $250M | 27 Feb 2019 | Cambridge, Massachusetts, United States |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent Blackstone Life Sciences?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 16
Average round size 263M
Peak activity year 2020
Lead investments 6
Follow on index 0.06
Exits 12
Group Appearance index 0.44
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
AvenCell | 22 Oct 2024 | Cambridge, Massachusetts, United States | |||
Uniquity Bio | $300M | 15 May 2024 | Malvern, Pennsylvania, United States | ||
Talaris Therapeutics | $115M | 06 Oct 2020 | Massachusetts, United States | ||
Praxis Precision Medicines | $110M | 28 Jul 2020 | Cambridge, Massachusetts, United States | ||
Annexon Biosciences | $100M | 01 Jul 2020 | South San Francisco, California, United States | ||
Anthos Therapeutics | $250M | 27 Feb 2019 | Cambridge, Massachusetts, United States |
